Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tapentadol 200mg modified-release capsules
0407020AGAAAMAM
|
Tapentadol | Tapentadol | Central Nervous System | 3 |
|
Tonpular XL 150mg capsules
0403040W0BSABAE
|
Tonpular | Venlafaxine | Central Nervous System | 3 |
|
Topiramate 20mg/ml oral solution sugar free
040801050AACICI
|
Topiramate | Topiramate | Central Nervous System | 3 |
|
Tramadol 75mg / Dexketoprofen 25mg tablets
040702040AABDBD
|
Tramadol hydrochloride | Tramadol hydrochloride | Central Nervous System | 3 |
|
Tryptophan 50mg capsules
0403040S0AAAGAG
|
Tryptophan | Tryptophan | Central Nervous System | 3 |
|
Vigabatrin 250mg/5ml oral solution
0408010X0AAATAT
|
Vigabatrin | Vigabatrin | Central Nervous System | 3 |
|
Xeomin 200unit powder for solution for injection vials
0409030B0BEACAG
|
Xeomin | Botulinum toxin type A | Central Nervous System | 3 |
|
Zonisamide 20mg/ml oral suspension sugar free
0408010ADAAAHAH
|
Zonisamide | Zonisamide | Central Nervous System | 3 |
|
Zubsolv 1.4mg/0.36mg sublingual tablets
0410030B0BCAAAG
|
Zubsolv | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 3 |
|
Aimovig 70mg/1ml solution for injection pre-filled pens
0407042T0BBAAAA
|
Aimovig | Erenumab | Central Nervous System | 2 |
|
Aprepitant 25mg/5ml oral suspension
0406000ADAAAEAE
|
Aprepitant | Aprepitant | Central Nervous System | 2 |
|
Aquipta 10mg tablets
0407042U0BBAAAA
|
Aquipta | Atogepant | Central Nervous System | 2 |
|
Atomoxetine 20mg/5ml oral suspension
0404000S0AAALAL
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | 2 |
|
Beechams All-In-One oral solution
0407010X0BTACBA
|
Beechams (Paracetamol combined) | Paracetamol combined preparations | Central Nervous System | 2 |
|
Botox 50unit powder for solution for injection vials
0409030B0BCABAD
|
Botox | Botulinum toxin type A | Central Nervous System | 2 |
|
Brivaracetam 50mg/5ml solution for injection vials
0408010ALAAAFAF
|
Brivaracetam | Brivaracetam | Central Nervous System | 2 |
|
Buprenorphine 16mg / Naloxone 4mg sublingual tab sugar free
0410030B0AAACAC
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 2 |
|
Buprenorphine 2mg / Naloxone 500microgram SL films SF
0410030B0AAADAD
|
Buprenorphine/naloxone (Opioid Dependance) | Buprenorph hydrochloride/naloxone hydrochloride | Central Nervous System | 2 |
|
Byannli 700mg/3.5ml prolonged-release inj pf syringes
0402020ABBDAAAK
|
Byannli | Paliperidone | Central Nervous System | 2 |
|
Carbagen 400mg tablets
0408010C0BFAEAD
|
Carbagen | Carbamazepine | Central Nervous System | 2 |
|
Carbamazepine 100mg chewable tablets sugar free
0408010C0AAAJAJ
|
Carbamazepine | Carbamazepine | Central Nervous System | 2 |
|
Chloral hydrate 100mg suppositories
0401010B0AAAXAX
|
Chloral hydrate | Chloral hydrate | Central Nervous System | 2 |
|
Chloral hydrate 100mg/5ml oral solution BP
0401010B0AABFBF
|
Chloral hydrate | Chloral hydrate | Central Nervous System | 2 |
|
Chloral hydrate 1mg/5ml oral solution BP
0401010B0AABJBJ
|
Chloral hydrate | Chloral hydrate | Central Nervous System | 2 |
|
Chlorpromazine 100mg/5ml oral suspension
0402010D0AAA2A2
|
Chlorpromazine hydrochloride | Chlorpromazine hydrochloride | Central Nervous System | 2 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.